13F Holdings
中文EN

BIVI BIOVIE INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1580149 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-22.3%
TTM EPS YoY54.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-143.7%
ROA-119.3%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets40.9%
Debt / equity0.00x
Current ratio2.40x
Interest coverage-1,363.57x

Cash quality & payout

Operating cash flow / net income0.84x
Accruals ratio-19.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue—————
R&D expense$13.96M$9.27M$23.10M$33.30M$17.26M
SG&A expense$8.51M$8.57M$8.85M$11.55M$9.77M
Operating income-$22.65M-$18.07M-$32.18M-$45.08M-$27.25M
Interest expense$17,901$332,720$2.89M$4.30M$2.16M
Net income-$22.07M-$17.54M-$32.12M-$50.26M-$26.08M
EPS (basic)-3.05-12.12-73.05-15.47-1.06
EPS (diluted)-3.05-12.12-73.05-15.47-1.06
Weighted avg. shares (diluted)7.25M1.48M451,8533.25M24.66M
Balance sheet
Cash & equivalents$8.98M$17.54M$23.84M$19.46M$18.64M
Current assets$13.64M$20.70M$24.05M$34.04M$18.78M
Goodwill$345,711$345,711$345,711$345,711$345,711
Intangibles—$178,341$407,718$637,095$866,472
Total assets$14.25M$21.56M$25.21M$35.10M$20.11M
Current liabilities$3.80M$2.27M$9.35M$14.49M$4.17M
Total liabilities$3.98M$2.55M$9.70M$19.76M$16.44M
Shareholders' equity$10.27M$19.01M$15.51M$15.34M$3.67M
Shares outstanding7.54M1.91M619,0083.64M24.98M
Cash flow statement
Operating cash flow-$19.02M-$19.03M-$27.95M-$40.25M-$18.99M
Investing cash flow——$14.53M-$14.30M—
Financing cash flow$10.46M$12.73M$17.80M$55.37M$33.12M
Stock-based compensation$2.28M$1.20M$2.82M$4.22M$5.81M

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.